Changes in humoral and cellular immunity in patients operated on due to esophageal cancer;Zaburzenia odporności humoralnej i komórkowej u chorych operowanych z powodu raka przełyku

Polski Merkuriusz Lekarski

Volumn 18, Issue 106, 2005, Pages 478-482

  Szczȩsny, Tomasz ^a   Słotwinski, Robert ^b,c   Szczȩsny, Grzegorz ^b,c  

^a Oddział Chirurgii Klatki Piersiowej Miejskiego Szpitala Zespolonego W Olsztynie ^*  (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Cellular immunity; Complications; Esophageal carcinoma; Hummoral immunity

Indexed keywords

CELLULAR IMMUNITY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; MALNUTRITION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RESPIRATORY TRACT DISEASE; REVIEW; SURGICAL RISK;

ANTIBODY FORMATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; MALNUTRITION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 18444414558     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Abe T. i wsp.: Interleukin-6 production in lung tissue after transthoracic esophagectomy. J. Am. Coll. Surg., 2001, 192(3), 322-9.
2. Aosasa S. i wsp.: Activation of Monocytes and Endothelial Cells Depends on the Severity of Surgical Stress. World Journal of Surgery, 2000, 24, 10-16.
3. Bentdal O. i wsp.: Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus. Cancer Lett., 1996, 100(1-2), 133-8.
4. Chau I. i wsp.: Perioperative chemiotherapy for cancer of the esophagus and the esophagogastric function. ASCO Annual Meeting Educational Book, 2003, 429-440.
5. Cheadle W. i wsp.: HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am. J. Surg., 1991, 161(6), 639-45.
6. Cheadle W.: The human leukocyte antigens and their relationship to infection. Am. J. Surg., 1993, 165, 75s.
7. Da̧browski A. i wsp.: Epidemiologia raka przełyku w Polsce. Pol. Merkuriusz Lek., 1998, 5(26), 84-6.
8. Fukunaga T. i wsp.: Kinetics of cytokines and PMN-E in thoracoscopic esophagectomy. Surg. Endosc., 2001, 15(12), 1484-7.
9. Gunderson L. i wsp.: Chemoradiation for esophageal cancer. ASCO Educational Book, 2003, 441-9.
10. Katsuta T. i wsp.: Relation between tumor necrosis factor α and interleukin 1β producing capacity of peripheral monocytes and pulmonary complications following oesophagectomy. British Journal of Surgery, 1998, 85, 548-553.
11. Kinugasa S. i wsp.: Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann. Thorac. Surg., 2001, 71(2), 414-8.
12. Kono K. i wsp.: Influence of surgical stress on monocytes and complications of infection in patients with esophageal cancer - monocyte HLA-DR antigen expression and respiratory burst capacity. Journal of Surgical Research, 1995, 58, 275-280.
13. Kono K. i wsp.: Effect of oesophagectomy on monocyte-induced apoptosis of peripheral blood T lymphocytes. Br. J. Surg., 2001, 88(8), 1110-6.
14. Kooguchi K. i wsp.: Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy. Crit. Care. Med., 2002, 30(1), 71-6.
15. Little D. i wsp.: Perioperative immune modulation. Surgery, 1993, 114, 87-91.
16. Muehlstedt S. i wsp.: Cytokines and the pathogenesis of nosocomial pneumonia. Surgery, 2001, 130(4), 602-9; dyskusja 609-11.
17. Nakamura K. i wsp.: Influence of p reoperative nutritional state on inflammatory response after surgery. Nutrition, 1999, 15, 834-841.
18. Nozoe T. i wsp.: Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur. J. Surg. Oncol., 2002, 28(4), 396-400.
19. Oka M. i wsp.: Immunosuppression in patients with Barrett's esophagus. Surgery, 1992, 112(1), 11-7.
20. Okawa K. i wsp.: Systemic and pulmonary responses of inflammatory cytokines following esophagectomy. Nippon Ika Daigaku Zasshi., 1998, 65(1), 42-9.
21. Pardela M.: Diagnostyka i postȩpowanie w raku przełyku. Śla̧ska Akademia Medyczna, Katowice 2001.
22. Polkowski W. i wsp.: Prognostyczne znaczenie odporności komórkowej w chirurgicznym leczeniu raka przełyku. Wiad. Lek., 1997, 50(1), 348-351.
23. Sakamoto K. i wsp.: Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine, 1994, 6(2), 181-6.
24. Sato N. i wsp.: Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. Eur. Surg. Res., 2001, 33, 279-284.
25. Szawłowski A. i wsp.: Preoperative concurrent chemotherapy and radiotherapy for local-regional and advanced squamous cell carcinoma of the thoracic oesophagus: preliminary results of a pilot study. Eur. J. Surg. Oncol., 1991, 17(6), 575-80.
26. Szczygieł B. i wsp.: Interwencja żywieniowa w chorobach ukłedu pokarmowego. Gastroenterologia Polska, 1997, 4(5), 501-515.
27. Takemura M. i wsp.: Changes of serum cytokine levels after thoracoscopic esophagectomy. Jpn. J. Thorac. Cardiovasc. Surg., 1998, 46(12), 1305-10.
28. Tashiro T. i wsp.: Changes in immune function following surgery for esophageal carcinoma. Nutrition, 1999, 15(10), 760-6.
29. Toge T. i wsp.: Surgical stress and immuno-suppression in cancer patients. Gan To Kagaku Ryoho, 1989, 16, 1115-21.
30. Tsukada K. i wsp.: Predictive value of interleukin-8 and granulocyte elastase in pulmonary complication after esophagectomy. Am. J. Surg., 2001, 18(12), 167-71.
31. Watanabe S. i wsp.: Significance of systemic inflammatory response syndrome after surgical treatment for thoracic esophageal cancer. Jpn. J. Thorac. Cardiovasc. Surg., 1998, 46(6), 549-55.
32. Yamada T. i wsp.: Serum Interleukin-6, Interleukin-8, Hepatocyte Growth Factor and Nitric Oxide Changes during Thoracic Surgery. World Journal of Surgery, 1998, 22, 783-790.